L1CAM: amending the “low-risk” category in endometrial carcinoma

[1]  M. Kamal,et al.  Influence of Comorbidity on the Risk of Death: A Single Institution Study of 1132 Women With Early-stage Uterine Cancer , 2017, American journal of clinical oncology.

[2]  B. Schönfisch,et al.  Second Opinion Expert Pathology in Endometrial Cancer: Potential Clinical Implications , 2017, International Journal of Gynecologic Cancer.

[3]  K. K. van de Vijver,et al.  L1CAM expression in endometrial carcinomas: an ENITEC collaboration study , 2016, British Journal of Cancer.

[4]  B. Davidson,et al.  L1CAM as a prognostic marker in stage I endometrial cancer: a validation study , 2016, BMC Cancer.

[5]  C. Ouyang,et al.  L1CAM is an independent predictor of poor survival in endometrial cancer - An analysis of The Cancer Genome Atlas (TCGA). , 2016, Gynecologic oncology.

[6]  E. Darai,et al.  Endometrial cancer , 2016, The Lancet.

[7]  P. Altevogt,et al.  L1CAM Expression is Related to Non-Endometrioid Histology, and Prognostic for Poor Outcome in Endometrioid Endometrial Carcinoma , 2016, Pathology & Oncology Research.

[8]  J. Ledermann,et al.  ESMO-ESGO-ESTRO consensus conference on endometrial cancer: Diagnosis, treatment and follow-up. , 2015, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[9]  A. Talhouk,et al.  A clinically applicable molecular-based classification for endometrial cancers , 2015, British Journal of Cancer.

[10]  D. Provencher,et al.  Gynecologic Cancer InterGroup (GCIG) Consensus Review for Uterine Serous Carcinoma , 2014, International Journal of Gynecologic Cancer.

[11]  T. Bosse,et al.  L1 cell adhesion molecule is a strong predictor for distant recurrence and overall survival in early stage endometrial cancer: pooled PORTEC trial results. , 2014, European journal of cancer.

[12]  P. Altevogt,et al.  A Standardized Staining Protocol for L1CAM on Formalin-Fixed, Paraffin-Embedded Tissues Using Automated Platforms , 2014, The International journal of biological markers.

[13]  P. Altevogt,et al.  L1CAM in early-stage type I endometrial cancer: results of a large multicenter evaluation. , 2013, Journal of the National Cancer Institute.

[14]  A. Reuss,et al.  Specialized Pathology Review in Patients With Ovarian Cancer: Results From a Prospective Study , 2013, International Journal of Gynecologic Cancer.

[15]  Marta García,et al.  The EMT signaling pathways in endometrial carcinoma , 2012, Clinical and Translational Oncology.

[16]  P. Altevogt,et al.  L1CAM , 2012, Cell adhesion & migration.

[17]  T. Herzog,et al.  Contemporary management of endometrial cancer , 2012, The Lancet.

[18]  P. Altevogt,et al.  Up‐regulation of L1CAM is linked to loss of hormone receptors and E‐cadherin in aggressive subtypes of endometrial carcinomas , 2010, The Journal of pathology.

[19]  W. Birchmeier,et al.  Interplay of cadherin-mediated cell adhesion and canonical Wnt signaling. , 2010, Cold Spring Harbor perspectives in biology.

[20]  A. Ben-Ze'ev,et al.  L1 cell adhesion molecule (L1CAM) in invasive tumors. , 2009, Cancer letters.

[21]  E. Fischer,et al.  The soluble form of the cancer-associated L1 cell adhesion molecule is a pro-angiogenic factor. , 2009, The international journal of biochemistry & cell biology.

[22]  C. Stewart,et al.  Immunophenotypic features of MELF pattern invasion in endometrial adenocarcinoma: evidence for epithelial–mesenchymal transition , 2009, Histopathology.

[23]  E. Trimble,et al.  Endometrial Cancer State of the Science Meeting , 2009, International Journal of Gynecologic Cancer.

[24]  P. Altevogt,et al.  L1 expression as a predictor of progression and survival in patients with uterine and ovarian carcinomas , 2003, The Lancet.

[25]  M. Schachner,et al.  Immunocytological and biochemical characterization of a new neuronal cell surface component (L1 antigen) which is involved in cell adhesion. , 1984, The EMBO journal.

[26]  M. Post.  Endometrial carcinoma: controversies in histopathological assessment of grade and tumour cell type , 2011 .

[27]  Patrick Neven,et al.  Endometrial cancer. , 2005, Lancet.

[28]  R. Pearcey,et al.  An analysis of the impact of pathology review in gynecologic cancer. , 2000, International journal of radiation oncology, biology, physics.